Characterization of Long-Acting Beta-Adrenergic Agonists Use for Asthma Treatment

被引:0
|
作者
Kaplan, Sigal [1 ]
Zhou, Esther [1 ]
机构
[1] US FDA, Silver Spring, MD USA
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
577
引用
收藏
页码:S251 / S252
页数:2
相关论文
共 50 条
  • [1] The future of the long-acting beta-adrenergic bronchodilators in the treatment of asthma
    Mansfield, Lyndon E.
    ALLERGY AND ASTHMA PROCEEDINGS, 2008, 29 (02) : 103 - 108
  • [2] Characterization of Long-Acting Beta2-Adrenergic Agonists Utilization in Asthma Patients
    Kaplan, Sigal
    Zhou, Esther H.
    Iyasu, Solomon
    JOURNAL OF ASTHMA, 2012, 49 (10) : 1079 - 1085
  • [3] ROUTINE USE OF BETA-ADRENERGIC AGONISTS IN ASTHMA
    WANNER, A
    SEARS, MR
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (02) : 823 - 823
  • [4] Long-Acting Beta-Agonists in Asthma
    Knobil, Katharine
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (02): : 208 - 209
  • [5] Long-acting beta Agonists in asthma therapy
    Rissmiller, RW
    Larj, MJ
    Peters, SP
    CURRENT ALLERGY AND ASTHMA REPORTS, 2004, 4 (02) : 91 - 92
  • [6] Long-acting beta agonists in asthma therapy
    Richard W. Rissmiller
    Michael J. Larj
    Stephen P. Peters
    Current Allergy and Asthma Reports, 2004, 4 : 91 - 92
  • [7] The FDA and Safe Use of Long-Acting Beta-Agonists in the Treatment of Asthma.
    Chowdhury, Badrul A.
    Dal Pan, Gerald
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (13): : 1169 - 1171
  • [8] BETA-ADRENERGIC AGONISTS IN ASTHMA
    NEE, C
    HERZFELD, J
    COONCE, SL
    MURPHY, CM
    SIMON, PA
    CLINICAL PHARMACY, 1992, 11 (01): : 13 - 14
  • [9] Long-acting beta-2 agonists in the treatment of asthma.
    Boniface, S
    Magnan, A
    Vervloet, D
    REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE, 1998, 38 (10): : 972 - 978
  • [10] Use of Long-Acting β-Agonists in Asthma in Spain
    Afonso, Ana
    Huerta, Consuelo
    Gil, Miguel
    Oliva, Belen
    Bryant, Veronica
    Montero, Dolores
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 476 - 476